FY2026 · ended Jun 30, 2026 · Revenue $254.25B, +14.2% YoY · Filed Aug 11, 2026
Cardinal Health, Inc. (CAH) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $254.2 billion and net income of $1.7 billion. Free cash flow was $4.5 billion. As of Jun 30, 2026 it held $4.9 billion in cash and investments and $9.9 billion in total debt.
Revenue
$254.25B
+14.2% vs prior year
Net income
$1.71B
+9.8% vs prior year
Operating cash flow
$5.17B
+115.9% vs prior year
Free cash flow
$4.53B
+144.6% vs prior year
EPS
$7.23
+12.1% vs prior year
Dividend per share
$2.04
+1.0% vs prior year
Shares outstanding
232.58M
-2.6% vs prior year
Net cash
$-5.09B
FY 2026
Operating margin
1.0%
FY 2026
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- CAH (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- OH
- Headquarters
- Dublin, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 721371
- Former names
- CARDINAL HEALTH INC (until Nov 5, 2026); CARDINAL DISTRIBUTION INC (until Feb 17, 1994)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $254.2B | $222.6B | $226.8B | $205.0B | $181.3B |
| Operating income | $2.6B | $2.3B | $1.2B | $752.0M | -$607.0M |
| Net income | $1.7B | $1.6B | $852.0M | $330.0M | -$938.0M |
| Diluted EPS | $7.23 | $6.45 | $3.45 | $1.26 | -$3.37 |
| Operating cash flow | $5.2B | $2.4B | $3.8B | $2.8B | $3.2B |
| Free cash flow | $4.5B | $1.9B | $3.3B | $2.4B | $2.8B |
| Total assets | $57.3B | $53.1B | $45.1B | $43.3B | $43.9B |
| Stockholders' equity | -$2.9B | -$2.8B | -$3.2B | -$3.0B | -$709.0M |
| Cash and investments | $4.9B | $3.9B | $5.3B | $4.1B | $4.7B |
| Total debt | $9.9B | $9.3B | $5.6B | $5.2B | $5.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| ARS | Annual report to shareholders | Sep 21, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
All 1002 Cardinal Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.